GlassScriptPhysician profile
Vineel Kurli
NPI 1093954554
$955.20
in general payments reported to CMS, 2019-2025
6 companies · $456 in 2025
The $456 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2021: $11.66 · 2022: $135 · 2023: $49.96 · 2024: $157 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358 · Travel and Lodging: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.48 |
| Travel and Lodging | $304.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $424.67 | 2025 | |
| Trisalus Life Sciences, INC. | $157.33 | 2024 | Trinav Infusion System |
| Argon Medical Devices, INC. | $145.74 | 2019 | |
| Terumo Medical Corporation | $122.48 | 2022 | |
| Medtronic, INC. | $92.62 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Bard Peripheral Vascular, INC. | $12.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vineel Kurli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.